Singapore plans to support the local development and production of new mRNA influenza vaccines to enhance national preparedness for future pandemics, Health Minister Ong Ye Kung announced Thursday.
The Ministry of Health intends to work with medical research organizations like Hilleman Laboratories, which is headquartered in Singapore and has a local manufacturing facility, to develop new mRNA vaccines.
Besides Hilleman, Singapore is also working with companies with capabilities across vaccine platforms and manufacturing, including Sanofi, GSK, Moderna and Thermo Fisher Scientific.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments